search
Back to results

Swaddling to Improve Neurodevelopment for Preterm Babies

Primary Purpose

Preterm Birth, Neurodevelopmental Disorders

Status
Not yet recruiting
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Novel Swaddle
Sponsored by
Johns Hopkins University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional supportive care trial for Preterm Birth focused on measuring Preterm, Brain, Neurodevelopment, Swaddling

Eligibility Criteria

24 Weeks - 37 Weeks (Child)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Born very preterm (<32 weeks postmenstrual age (PMA))
  • At least 12 hours and less than 2 months old
  • Expected to survive > 3 days
  • No congenital anomaly or genetic disorder with expected survival less than term equivalent
  • No malformations requiring surgery within 1 month of life
  • Central intravenous lines removed
  • Approval of the primary neonatologist, ideally not a study team member, to approach family for consent
  • Appropriate parent or guardian to provide informed consent

Exclusion Criteria:

  • Life expectancy < 3 days
  • Severe congenital anomaly or genetic disorder with life expectancy <40 weeks PMA
  • Seizures
  • Need for seizure medication
  • Hypertension for age requiring medication
  • Severe hematologic crisis such as disseminated intravascular coagulation
  • Hydrops fetalis
  • Clinical concern or diagnosis of toxoplasmosis, cytomegalovirus rubella or syphilis infection
  • Clinical concern or diagnosis of severe acute respiratory distress syndrome coronavirus 2 (SARS CoV-2) or coronavirus disease (COVID-19)
  • Central intravenous access and reliance on parenteral nutrition >50%
  • Respiratory support greater than nasal canulae or nasal continuous positive airway pressure (CPAP) (i.e. ventilator dependent)
  • Active infection, including need for antibiotics greater than 5 days (i.e. confirmed infection)
  • Complex congenital heart disease
  • Known chromosomal abnormalities
  • Clinical or echocardiographic signs of symptomatic pulmonary hypertension
  • Profound perinatal hypoxia-ischemia
  • Receiving treatment for pain control
  • Sustained tachypnea >80 breaths/minute
  • Need for volume expansion or administration of inotropes
  • No one available or willing to provide consent

Sites / Locations

    Arms of the Study

    Arm 1

    Arm 2

    Arm Type

    No Intervention

    Experimental

    Arm Label

    Conventional Swaddle

    Novel Swaddle

    Arm Description

    The management of the non-intervention group is with a cotton swaddle that is standard of care. It represents a conventional standard management method using a swaddle made of cotton.

    The Novel Swaddle is made of fabric consisting of 85% nylon and 15% polyurethane. This fabric provides heat retention, is hygroscopic and stretches in both longitudinal and transverse directions, thus more accurately replicating the intrauterine environment. The novel material is sewed into a bag shape.

    Outcomes

    Primary Outcome Measures

    Change in Sleep-Wake Cycling Maturity as assessed by amplitude integrated EEG (aEEG) readings
    Using aEEG, the Investigators will assess the presence or absence of mature sleep-wake cycling as defined as regular rhythmic sinusoidal variations of amplitude with a cycle greater than or equal to 20 minutes. Tracings with a cycling pattern that does not fit into a mature sleep-wake cycle for the majority of the tracing will be classified as intermediate.
    Change in length of time spent in sleep
    Using aEEG, the Investigators will assess the change in length of time (in minutes) spent in sleep.
    Change in the number of awakenings in a 3 hour time period
    Using aEEG, the Investigators will assess the change in number of awakenings in a 3 hour time period.
    Change in voltage as assessed by aEEG) readings
    Using aEEG, the Investigators will assess the change in voltage (measured in microvolts).
    Change in ratio of active sleep and quiet sleep as assessed by amplitude integrated EEG (aEEG) readings
    Using aEEG The Investigators will assess the time spent in active sleep (irregular and low in amplitude) and quiet sleep (regular and high in amplitude).
    Change in Sleep-Wake Cycling Continuity as assessed by amplitude integrated EEG (aEEG) readings
    Using aEEG The Investigators will examine the background activity on recordings to assess the presence or absence of isoelectric periods along with amplitude fluctuations. Tracings will be classified as continuous, discontinuous and borderline.

    Secondary Outcome Measures

    Behavioral Maturity as assessed by the NNNS
    The NICU Network Neurobehavioural Scale (NNNS) is a standardized clinical assessment tool used to assess neurological integrity and organization in a single, structured clinical exam. Summary scores are created for neurobehavioral domains including: habituation, attention, handling, quality of movement, self-regulation, non optimal reflexes, asymmetrical reflexes, stress/abstinence, arousal, hypertonicity, excitability, and lethargy. 13 summary scores will be generated.
    Change in General Movements as assessed by the GMA
    Prechtl's General Movement Assessment (GMA) is a clinical assessment tool that classifies writhing movements in preterm infants. Specifically, classification of writhing movements will be made as cramped synchronous, poor repertoire with cramped synchronicity, or poor repertoire.

    Full Information

    First Posted
    January 14, 2021
    Last Updated
    August 7, 2023
    Sponsor
    Johns Hopkins University
    Collaborators
    The Thomas Wilson Sanitarium for Children of Baltimore City
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT04715451
    Brief Title
    Swaddling to Improve Neurodevelopment for Preterm Babies
    Official Title
    A Novel Swaddling Method To Improve Developmental Care for Preterm Babies
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    August 2023
    Overall Recruitment Status
    Not yet recruiting
    Study Start Date
    December 1, 2023 (Anticipated)
    Primary Completion Date
    May 2025 (Anticipated)
    Study Completion Date
    May 2026 (Anticipated)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Sponsor
    Name of the Sponsor
    Johns Hopkins University
    Collaborators
    The Thomas Wilson Sanitarium for Children of Baltimore City

    4. Oversight

    Studies a U.S. FDA-regulated Drug Product
    No
    Studies a U.S. FDA-regulated Device Product
    No
    Data Monitoring Committee
    Yes

    5. Study Description

    Brief Summary
    The investigators will test a new medical grade swaddling system for optimal and more appropriate positioning for preterm infants. This is a trial focused on sleep state, state regulation and long-term neurodevelopment. The central hypothesis is that this novel swaddling method will promote sleep and an optimal sleep-wake cycle, while also improving the neurodevelopment of preterm infants. It is proposed that adequate positioning and secondary feedback of natural movement of arms and legs stimulates and fosters normal brain development.
    Detailed Description
    Throughout pregnancy, the fetus is encouraged to develop by maintaining proper flexed posture in the uterus and freely moving its arms and legs against the flexible boundaries of the womb. However, when born too early, preterm infants lose the natural boundaries of the womb that support this flexor positioning and movement support. In addition preterm infants undergo stress because of essential treatments in neonatal intensive care units and exposure to the extrauterine environment. To support the development of preterm infants, cotton wraps are often used to maintain appropriate body positioning. Swaddling helps maintain continuous and adequate body positioning which aids and provides a stable sleep environment and encourages muscle tone. However, traditional swaddling is challenging in preterm infants and preterm infants frequently become unswaddled. It is fraught with difficulties related to the neonatal care and monitoring preterm infants receive due to the prematurity. In addition, this stiff material does not provide the same sensory experience as the flexible boundaries of the womb. In response to this challenge, The Investigators developed a new medical grade swaddling system for optimal and more appropriate positioning and natural movement. Here, The Investigators outline a trial focused on sleep state, state regulation and long-term neurodevelopment. The central hypothesis is that this novel swaddling method will promote sleep and an optimal sleep-wake cycle, while also improving the neurodevelopment of preterm infants. It is proposed that adequate positioning and secondary feedback of natural movement of arms and legs stimulates and fosters normal brain development. The Investigators will clinically evaluate sleep at the level of amplitude-integrated electroencephalograph (aEEG) activity and perform the Prechtl's Assessment of General Movements (GMA) to assess spontaneous writhing and fidgety movements, which predicts the future neurodevelopment of preterm babies. The Investigators will also perform the Neonatal Intensive Care Unit (NICU) Network Neurobehavioural Scale (NNNS) as a standardized assessment of neurological integrity and organization. The goal is to provide early intervention to improve development in preterm infants.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Preterm Birth, Neurodevelopmental Disorders
    Keywords
    Preterm, Brain, Neurodevelopment, Swaddling

    7. Study Design

    Primary Purpose
    Supportive Care
    Study Phase
    Not Applicable
    Interventional Study Model
    Parallel Assignment
    Masking
    Outcomes Assessor
    Allocation
    Randomized
    Enrollment
    60 (Anticipated)

    8. Arms, Groups, and Interventions

    Arm Title
    Conventional Swaddle
    Arm Type
    No Intervention
    Arm Description
    The management of the non-intervention group is with a cotton swaddle that is standard of care. It represents a conventional standard management method using a swaddle made of cotton.
    Arm Title
    Novel Swaddle
    Arm Type
    Experimental
    Arm Description
    The Novel Swaddle is made of fabric consisting of 85% nylon and 15% polyurethane. This fabric provides heat retention, is hygroscopic and stretches in both longitudinal and transverse directions, thus more accurately replicating the intrauterine environment. The novel material is sewed into a bag shape.
    Intervention Type
    Other
    Intervention Name(s)
    Novel Swaddle
    Intervention Description
    A novel swaddling method.
    Primary Outcome Measure Information:
    Title
    Change in Sleep-Wake Cycling Maturity as assessed by amplitude integrated EEG (aEEG) readings
    Description
    Using aEEG, the Investigators will assess the presence or absence of mature sleep-wake cycling as defined as regular rhythmic sinusoidal variations of amplitude with a cycle greater than or equal to 20 minutes. Tracings with a cycling pattern that does not fit into a mature sleep-wake cycle for the majority of the tracing will be classified as intermediate.
    Time Frame
    32 weeks postmenstrual age, 34 weeks postmenstrual age and 36 weeks postmenstrual age
    Title
    Change in length of time spent in sleep
    Description
    Using aEEG, the Investigators will assess the change in length of time (in minutes) spent in sleep.
    Time Frame
    32 weeks postmenstrual age, 34 weeks postmenstrual age and 36 weeks postmenstrual age
    Title
    Change in the number of awakenings in a 3 hour time period
    Description
    Using aEEG, the Investigators will assess the change in number of awakenings in a 3 hour time period.
    Time Frame
    32 weeks postmenstrual age, 34 weeks postmenstrual age and 36 weeks postmenstrual age
    Title
    Change in voltage as assessed by aEEG) readings
    Description
    Using aEEG, the Investigators will assess the change in voltage (measured in microvolts).
    Time Frame
    32 weeks postmenstrual age, 34 weeks postmenstrual age and 36 weeks postmenstrual age
    Title
    Change in ratio of active sleep and quiet sleep as assessed by amplitude integrated EEG (aEEG) readings
    Description
    Using aEEG The Investigators will assess the time spent in active sleep (irregular and low in amplitude) and quiet sleep (regular and high in amplitude).
    Time Frame
    32 weeks postmenstrual age, 34 weeks postmenstrual age and 36 weeks postmenstrual age
    Title
    Change in Sleep-Wake Cycling Continuity as assessed by amplitude integrated EEG (aEEG) readings
    Description
    Using aEEG The Investigators will examine the background activity on recordings to assess the presence or absence of isoelectric periods along with amplitude fluctuations. Tracings will be classified as continuous, discontinuous and borderline.
    Time Frame
    32 weeks postmenstrual age, 34 weeks postmenstrual age and 36 weeks postmenstrual age
    Secondary Outcome Measure Information:
    Title
    Behavioral Maturity as assessed by the NNNS
    Description
    The NICU Network Neurobehavioural Scale (NNNS) is a standardized clinical assessment tool used to assess neurological integrity and organization in a single, structured clinical exam. Summary scores are created for neurobehavioral domains including: habituation, attention, handling, quality of movement, self-regulation, non optimal reflexes, asymmetrical reflexes, stress/abstinence, arousal, hypertonicity, excitability, and lethargy. 13 summary scores will be generated.
    Time Frame
    37 weeks postmenstrual age
    Title
    Change in General Movements as assessed by the GMA
    Description
    Prechtl's General Movement Assessment (GMA) is a clinical assessment tool that classifies writhing movements in preterm infants. Specifically, classification of writhing movements will be made as cramped synchronous, poor repertoire with cramped synchronicity, or poor repertoire.
    Time Frame
    32 weeks postmenstrual age and 37 weeks postmenstrual age

    10. Eligibility

    Sex
    All
    Minimum Age & Unit of Time
    24 Weeks
    Maximum Age & Unit of Time
    37 Weeks
    Accepts Healthy Volunteers
    No
    Eligibility Criteria
    Inclusion Criteria: Born very preterm (<32 weeks postmenstrual age (PMA)) At least 12 hours and less than 2 months old Expected to survive > 3 days No congenital anomaly or genetic disorder with expected survival less than term equivalent No malformations requiring surgery within 1 month of life Central intravenous lines removed Approval of the primary neonatologist, ideally not a study team member, to approach family for consent Appropriate parent or guardian to provide informed consent Exclusion Criteria: Life expectancy < 3 days Severe congenital anomaly or genetic disorder with life expectancy <40 weeks PMA Seizures Need for seizure medication Hypertension for age requiring medication Severe hematologic crisis such as disseminated intravascular coagulation Hydrops fetalis Clinical concern or diagnosis of toxoplasmosis, cytomegalovirus rubella or syphilis infection Clinical concern or diagnosis of severe acute respiratory distress syndrome coronavirus 2 (SARS CoV-2) or coronavirus disease (COVID-19) Central intravenous access and reliance on parenteral nutrition >50% Respiratory support greater than nasal canulae or nasal continuous positive airway pressure (CPAP) (i.e. ventilator dependent) Active infection, including need for antibiotics greater than 5 days (i.e. confirmed infection) Complex congenital heart disease Known chromosomal abnormalities Clinical or echocardiographic signs of symptomatic pulmonary hypertension Profound perinatal hypoxia-ischemia Receiving treatment for pain control Sustained tachypnea >80 breaths/minute Need for volume expansion or administration of inotropes No one available or willing to provide consent
    Central Contact Person:
    First Name & Middle Initial & Last Name or Official Title & Degree
    Lauren Jantzie, PhD
    Phone
    410-614-4135
    Email
    LJantzie@jhmi.edu
    First Name & Middle Initial & Last Name or Official Title & Degree
    Shenandoah Robinson, MD
    Phone
    410-955-7851
    Email
    SRobin81@jhmi.edu
    Overall Study Officials:
    First Name & Middle Initial & Last Name & Degree
    Lauren Jantzie, PhD
    Organizational Affiliation
    Johns Hopkins University
    Official's Role
    Principal Investigator

    12. IPD Sharing Statement

    Plan to Share IPD
    No
    Citations:
    PubMed Identifier
    28675824
    Citation
    Kitase Y, Sato Y, Takahashi H, Shimizu M, Ishikawa C, Yamamoto H, Hayakawa M. A new type of swaddling clothing improved development of preterm infants in neonatal intensive care units. Early Hum Dev. 2017 Sep;112:25-28. doi: 10.1016/j.earlhumdev.2017.06.005. Epub 2017 Jul 1.
    Results Reference
    background

    Learn more about this trial

    Swaddling to Improve Neurodevelopment for Preterm Babies

    We'll reach out to this number within 24 hrs